Ledger.Open graph →
SEC Form D · Amendment · filed January 13, 2017

Decibel Therapeutics, Inc

Offering
$57.8M
Sold
$32.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jeffrey M. Jonas · Cambridge, MADirectorKevin P. Starr · Cambridge, MADirectorGeorge H. Scangos · Cambridge, MADirectorRoger H. Brown · Cambridge, MADirectorCraig H. Muir · Cambridge, MADirectorJens H. Eckstein · Cambridge, MADirectorThomas E. Zanecchia · Denver, CODirectorMatt Munson · Marina del Rey, CADirectorJohn J. Keilty · Cambridge, MAExecTroy H. Brennan · Cambridge, MADirectorSteven H. Holtzman · Cambridge, MAExec · DirectorMichael Neagle · Dallas, TXDirectorJohn Mattes · Dallas, TXDirectorGeorge H. Scangos · Cambridge, MADirectorRoger H. Brown · Cambridge, MADirectorCraig H. Muir · Cambridge, MADirectorJohn J. Keilty · Cambridge, MAExecTroy H. Brennan · Cambridge, MADirectorSteven H. Holtzman · Cambridge, MAExec · DirectorJens H. Eckstein · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗